{"disease":{"id":"apatinib","name":"apatinib"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03889626","title":"The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":242,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06485466","title":"TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":101,"lead_sponsor_name":"Guohui Xu","has_results":false},{"nct_id":"NCT03365765","title":"mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT03650738","title":"This Study Was a Prospective, One-arm Open Phase II Clinical Trial. A Systematic Review of the pCR of Apatinib in Combination With the Albumin Paclitaxel and Carboplatin Regimens for the Neoadjuvant Therapy of Triple-negative Breast Cancer, as Well as the Safety of Treatment","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT05512481","title":"Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT03428022","title":"Apatinib Combined With EGFR-TKI for Advanced Slow-progressed EGFR-TKI Resistant NSCLC","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":54,"lead_sponsor_name":"Shenzhen People's Hospital","has_results":false},{"nct_id":"NCT03129698","title":"The Efficacy and Safety of Apatinib Monotherapy in Maintenance Treatment of Extensive-stage Small-cell Lung Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":52,"lead_sponsor_name":"Junling Li","has_results":false},{"nct_id":"NCT03192735","title":"Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Chang-Ming Huang, Prof.","has_results":false},{"nct_id":"NCT03201146","title":"Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":48,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT07031154","title":"A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":43,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT03742193","title":"Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":43,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT03986515","title":"Apatinib Plus SHR1210 in Advanced Mucosal Melanoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT03913182","title":"Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":39,"lead_sponsor_name":"Shanghai Chest Hospital","has_results":false},{"nct_id":"NCT04188847","title":"First-line Chemotherapy for Recurrent Cervical Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT04834674","title":"DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Sichuan Cancer Hospital and Research Institute","has_results":false},{"nct_id":"NCT04180007","title":"Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT03228043","title":"Apatinib for Resectable Colorectal Cancer","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Nanchong Central Hospital","has_results":false}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}